Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 15/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | GLP1R | P43220 | 2/20 | 0.61 |
| ▸ | GCGR | P47871 | 1/20 | 0.61 |
| ▸ | GIPR | P48546 | 1/20 | 0.61 |
| ▸ | CCKBR | P32239 | 1/20 | 0.60 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683360 | 0.89 | C5AR1 (0.62) | IL23RGLP1RGCGRGIPR | |
| SCHEMBL29939662 | 0.89 | PRMT1 (0.64) | IL23R | |
| SCHEMBL30607309 | 0.89 | PTH1R (0.65) | IL23RRXFP1GLP1RGCGRGIPR | |
| SCHEMBL29898344 | 0.88 | GLP1R (0.72) | IL23RRXFP1GLP1RGCGRGIPR | |
| SCHEMBL30648454 | 0.88 | GLP1R (0.69) | IL23RGLP1RGCGRGIPRCCKBR | |
| SCHEMBL30658291 | 0.88 | GLP1R (0.73) | IL23RRXFP1GLP1RGCGRGIPR | |
| SCHEMBL30811926 | 0.88 | NPBWR1 (0.61) | IL23RRXFP1GLP1RGCGRGIPR | |
| SCHEMBL31174225 | 0.88 | PTH1R (0.66) | IL23RRXFP1GLP1RGCGRGIPR | |
| SCHEMBL11435178 | 0.88 | IL23R (0.66) | IL23R | |
| SCHEMBL31169784 | 0.87 | IL23R (0.69) | IL23RGLP1RGCGRGIPRCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383505-B2 | Nanoparticle for the remodeling of cancer-associated fibroblasts | UNIVERSITY OF SOUTH CAROLINA (US) | 2025-08-12 | — | — | US | disclosed |
| US-20230310331-A1 | NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS | UNIVERSITY OF SOUTH CAROLINA (US) | 2023-10-05 | — | — | US | disclosed |